{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "76-year-old man presented with a cough.",
        "clinical_data": {
          "HPI": [
            {
              "summary": "76-year-old man presented with a cough.",
              "associated_symptoms": [
                "C0010200"
              ]
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Chest CT revealed a 45-mm mass in the left upper lobe.",
        "clinical_data": {
          "imaging": [
            {
              "type": "Mass",
              "body_part": "Left upper lobe",
              "modality": "CT",
              "finding": "45-mm mass in the left upper lobe"
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Transbronchial tumor biopsies showed adenocarcinoma.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Transbronchial biopsy",
              "approach": "endoscopic",
              "location": "bronchus"
            }
          ],
          "diagnoses": [
            {
              "code": "C4_Cancer",
              "label": "Adenocarcinoma",
              "status": "active"
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "CT and bone scintigraphy revealed lung, pleura, and bone metastases.",
        "clinical_data": {
          "imaging": [
            {
              "type": "metastasis",
              "body_part": "lung",
              "modality": "CT",
              "finding": "metastasis",
              "impression": "metastasis"
            },
            {
              "type": "metastasis",
              "body_part": "pleura",
              "modality": "CT",
              "finding": "metastasis",
              "impression": "metastasis"
            },
            {
              "type": "metastasis",
              "body_part": "bone",
              "modality": "bone scintigraphy",
              "finding": "metastasis",
              "impression": "metastasis"
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Diagnosed with left upper lobe adenocarcinoma cT2bN3M1c stage IVB. Genetic analysis of the primary tumor revealed positivity for epidermal growth factor receptor (EGFR) (L858R) and CTNNB1 mutations.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0279639",
              "label": "Adenocarcinoma of lung",
              "status": "active",
              "onset_date": null
            }
          ],
          "imaging": [
            {
              "type": "C0024112",
              "body_part": "T-structure",
              "modality": "CT",
              "finding": "T2b",
              "impression": null,
              "date": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Treated with osimertinib (80 mg/day) as first-line therapy and achieved clinical improvement and a partial response.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C1613614",
              "dosage": "80 mg/day",
              "frequency": "daily",
              "modality": "oral",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "diagnoses": [
            {
              "code": "C0033684",
              "label": "Response, Partial",
              "status": "active",
              "onset_date": null
            }
          ],
          "HPI": [
            {
              "summary": "Achieved clinical improvement",
              "duration": null,
              "onset": null,
              "progression": null,
              "associated_symptoms": [],
              "alleviating_factors": [],
              "exacerbating_factors": []
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "Six months later, the tumor increased in size, indicating progressive disease. Osimertinib was stopped, and second\u2010line therapy with carboplatin (area under the curve 5) and pemetrexed (500\u2009mg/m2) was initiated.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0007667",
              "dosage": "area under the curve 5",
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": "C0009450"
            },
            {
              "drug": "C0598482",
              "dosage": "500 mg/m2",
              "frequency": null,
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": "C0009450"
            },
            {
              "drug": "C1611559",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": "C0009450"
            }
          ],
          "diagnoses": [
            {
              "code": null,
              "label": "progressive disease",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "node_step_index": 7,
        "content": "After",
        "clinical_data": {}
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient went from presenting with a cough to a chest CT revealing a 45-mm mass in the left upper lobe."
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "The 45-mm mass in the left upper lobe was biopsied and showed adenocarcinoma."
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Adenocarcinoma diagnosis led to further imaging with CT and bone scintigraphy, revealing lung, pleura, and bone metastases."
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Imaging of lung, pleura, and bone metastases led to diagnosis of left upper lobe adenocarcinoma cT2bN3M1c stage IVB. Genetic analysis of the primary tumor revealed positivity for epidermal growth factor receptor (EGFR) (L858R) and CTNNB1 mutations."
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Diagnosis of left upper lobe adenocarcinoma cT2bN3M1c stage IVB with EGFR (L858R) and CTNNB1 mutations led to treatment with osimertinib (80 mg/day) as first-line therapy and achieved clinical improvement and a partial response.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1613614"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "Treatment with osimertinib (80 mg/day) led to clinical improvement and a partial response for six months, after which the tumor increased in size, indicating progressive disease. Osimertinib was stopped, and second\u2010line therapy with carboplatin (area under the curve 5) and pemetrexed (500\u2009mg/m2) was initiated.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C1613614",
            "C0007667",
            "C0598482"
          ],
          "change_type": "discontinuation",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "Patient went from second-line therapy with carboplatin (area under the curve 5) and pemetrexed (500\u2009mg/m2) to after."
      }
    }
  ]
}